VK Paul on India's COVID vaccine policy; Covaxin has 78% efficacy | Frankly Speaking

On The Frankly Speaking with Navika Kumar, Dr Vinod K. Paul, Member (Health), NITI Aayog joins in an exclusive conversation about India's vaccine situation. Navika Kumar questions Paul about the Covaxin efficacy and also puts in a hard question- 'has India miscalculated the new vaccine policy?' 'We are fortunate to have a basket of vaccines.' Paul tells Navika, 'We are currently dealing with three vaccines. Three other vaccines are on the cusp, not too far. India awaits Cadila Zydus, Novavax & BioE.' Paul also states that 'time will show our (India's) vaccine policy as a role model', further claiming that the eventual production and availability of vaccines will be tremendous across the country. Watch the full video to know more about what the NITI Aayog member has to say to Navika about the COVID vaccine situation in the country only on TIMES NOW's Frankly Speaking.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting